Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
There have been increases in prescriptions of high strength opioids for chronic non-cancer pain (CNCP), but CNCP patients perceive themselves as being at low risk of opioid overdose and generally have limited overdose awareness. This study examined how an overdose prevention intervention (opioid saf...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204494/ https://www.ncbi.nlm.nih.gov/pubmed/37218970 http://dx.doi.org/10.3390/pharmacy11030088 |
_version_ | 1785045847262625792 |
---|---|
author | Schofield, Joe Parkes, Tessa Mercer, Fiona Foster, Rebecca Hnízdilová, Kristina Matheson, Catriona Steele, Wez McAuley, Andrew Raeburn, Fiona Skea, Lucy Baldacchino, Alexander |
author_facet | Schofield, Joe Parkes, Tessa Mercer, Fiona Foster, Rebecca Hnízdilová, Kristina Matheson, Catriona Steele, Wez McAuley, Andrew Raeburn, Fiona Skea, Lucy Baldacchino, Alexander |
author_sort | Schofield, Joe |
collection | PubMed |
description | There have been increases in prescriptions of high strength opioids for chronic non-cancer pain (CNCP), but CNCP patients perceive themselves as being at low risk of opioid overdose and generally have limited overdose awareness. This study examined how an overdose prevention intervention (opioid safety education, naloxone training, and take-home naloxone (THN)) delivered by community pharmacists for patients prescribed high-strength opioids for CNCP would work in practice in Scotland. Twelve patients received the intervention. CNCP patients and Community Pharmacists were interviewed about their experiences of the intervention and perceptions of its acceptability and feasibility. CNCP patients did not initially perceive themselves as being at risk of overdose but, through the intervention, developed insight into opioid-related risk and the value of naloxone. Pharmacists also identified patients’ low risk perceptions and low overdose awareness. While pharmacists had positive attitudes towards the intervention, they outlined challenges in delivering it under time and resource pressures and during the COVID-19 pandemic. Overdose prevention interventions are required in the CNCP population as this group has elevated risk factors for overdose but are commonly overlooked. Customised overdose prevention interventions for CNCP patients attend to gaps in overdose awareness and risk perceptions in this population. |
format | Online Article Text |
id | pubmed-10204494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102044942023-05-24 Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain Schofield, Joe Parkes, Tessa Mercer, Fiona Foster, Rebecca Hnízdilová, Kristina Matheson, Catriona Steele, Wez McAuley, Andrew Raeburn, Fiona Skea, Lucy Baldacchino, Alexander Pharmacy (Basel) Article There have been increases in prescriptions of high strength opioids for chronic non-cancer pain (CNCP), but CNCP patients perceive themselves as being at low risk of opioid overdose and generally have limited overdose awareness. This study examined how an overdose prevention intervention (opioid safety education, naloxone training, and take-home naloxone (THN)) delivered by community pharmacists for patients prescribed high-strength opioids for CNCP would work in practice in Scotland. Twelve patients received the intervention. CNCP patients and Community Pharmacists were interviewed about their experiences of the intervention and perceptions of its acceptability and feasibility. CNCP patients did not initially perceive themselves as being at risk of overdose but, through the intervention, developed insight into opioid-related risk and the value of naloxone. Pharmacists also identified patients’ low risk perceptions and low overdose awareness. While pharmacists had positive attitudes towards the intervention, they outlined challenges in delivering it under time and resource pressures and during the COVID-19 pandemic. Overdose prevention interventions are required in the CNCP population as this group has elevated risk factors for overdose but are commonly overlooked. Customised overdose prevention interventions for CNCP patients attend to gaps in overdose awareness and risk perceptions in this population. MDPI 2023-05-22 /pmc/articles/PMC10204494/ /pubmed/37218970 http://dx.doi.org/10.3390/pharmacy11030088 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Schofield, Joe Parkes, Tessa Mercer, Fiona Foster, Rebecca Hnízdilová, Kristina Matheson, Catriona Steele, Wez McAuley, Andrew Raeburn, Fiona Skea, Lucy Baldacchino, Alexander Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain |
title | Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain |
title_full | Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain |
title_fullStr | Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain |
title_full_unstemmed | Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain |
title_short | Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain |
title_sort | feasibility and acceptability of an overdose prevention intervention delivered by community pharmacists for patients prescribed opioids for chronic non-cancer pain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204494/ https://www.ncbi.nlm.nih.gov/pubmed/37218970 http://dx.doi.org/10.3390/pharmacy11030088 |
work_keys_str_mv | AT schofieldjoe feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT parkestessa feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT mercerfiona feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT fosterrebecca feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT hnizdilovakristina feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT mathesoncatriona feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT steelewez feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT mcauleyandrew feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT raeburnfiona feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT skealucy feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain AT baldacchinoalexander feasibilityandacceptabilityofanoverdosepreventioninterventiondeliveredbycommunitypharmacistsforpatientsprescribedopioidsforchronicnoncancerpain |